Mesirow Financial Investment Management’s Wells Fargo WFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
14,786
+50
+0.3% +$4.02K 0.02% 257
2026
Q1
$1.17M Sell
14,736
-602
-4% -$51.7K 0.02% 252
2025
Q4
$1.43M Sell
15,338
-2,925
-16% -$254K 0.03% 212
2025
Q3
$1.53M Buy
18,263
+467
+3% +$37.9K 0.03% 225
2025
Q2
$1.43M Sell
17,796
-19,268
-52% -$1.39M 0.03% 228
2025
Q1
$2.66M Buy
37,064
+19,333
+109% +$1.45M 0.05% 175
2024
Q4
$1.25M Sell
17,731
-16,733
-49% -$1.14M 0.02% 240
2024
Q3
$1.95M Buy
34,464
+18,138
+111% +$1.03M 0.04% 199
2024
Q2
$970K Sell
16,326
-1,286
-7% -$75.9K 0.02% 252
2024
Q1
$1.02M Buy
17,612
+2,042
+13% +$107K 0.02% 250
2023
Q4
$766K Buy
+15,570
New +$672K 0.03% 252

Other funds holding WFC

Mesirow Financial Investment Management's WFC Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Wells Fargo (WFC) stake by 0.34% in Q2 2026, buying an estimated $4.02K and bringing the position to 14,786 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #257.

Mesirow Financial Investment Management first reported a position in WFC in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.66M in Q1 2025. 1,000 funds tracked by Wall St. Rank hold WFC as of Q2 2026.

  • Mesirow Financial Investment Management held 14,786 shares of Wells Fargo worth $1.22M as of Q2 2026.
  • Mesirow Financial Investment Management bought 50 Wells Fargo shares in Q2 2026, an estimated $4.02K.
  • Wells Fargo made up 0.02% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #257 holding.
  • Mesirow Financial Investment Management first reported a position in Wells Fargo in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's Wells Fargo position peaked at $2.66M in Q1 2025.
  • 1,000 funds tracked by Wall St. Rank held Wells Fargo as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.